cGxP.wire https://validator.w3.org/feed/docs/rss2.html Thryv Therapeutics Advances THRV-1268 for Heart Failure Care Dualitas Therapeutics and Roche Launch $1B Bispecific Collaboration Fennec Pharmaceuticals Presents Two-Year Pedmark Data in Japan Bristol Myers Squibb Reports Durable Sotyktu Results in PsA Orbis Medicines and Novo Nordisk Form $1.4B Discovery Deal Synergy Spine Solutions Reports Two-Year Synergy Disc Outcomes Aquestive Resubmits Anaphylm NDA to FDA Kamada Confirms KedRAB Supply Amid Rising U.S. Rabies Demand Nabsys Electronic Genome Mapping Advances Cancer Analysis OncoC4 Receives FDA Fast Track for Cesalatamig Viatris WAKIX Approved in Japan for Sleep Disorders MitoRx to Present MTRX31 Obesity Data at EASD 2026 Nona Biosciences Develops AI Model for Human Antibodies Sunshine Biopharma Advances PLpro Inhibitor Toward IND Curi Bio Advances FDA ISTAND Qualification for BoNT Assay SMSbiotech Advances COPD Program With FDA IND Clearance Aptitude Metrix COVID Test Receives FDA 510(k) Clearance A2 Biotherapeutics Advances A2B395 in Solid Tumors Gilead and PAHO Expand Lenacapavir HIV Prevention Access Merz Therapeutics Gains EU Approval for XEOMIN in Pediatric Spasticity DifGen Pharmaceuticals Wins FDA Approval for Epinephrine Genentech Advances Lunsumio in Phase III Follicular Lymphoma Boehringer Ingelheim Launches PED Essentials for Patient Evidence SNIPR Advances SNIPR001 Into Phase 2 for E. coli Prevention SetPoint Medical Expands RA Neuroimmune Therapy in Oregon IASO Bio IASO208 Receives FDA IND Clearance Eisai, Biogen LEQEMBI Pen Approved in Japan for Alzheimer’s Longeveron Reports ELPIS II Results for Laromestrocel Cambium Bio Advances Elate Ocular Into Phase 3 Galderma Advances Restylane Volyme in Chinese Temple Hollowing Chemify Raises £22M to Scale AI-Driven Chemistry Circle Pharma Raises $92.5M to Advance CID-165 Twist Bioscience Joins Lilly TuneLab for Antibody Discovery Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia Gilead Accelerates Global Access Planning for Once-Yearly Lenacapavir Mission Bio Launches Tapestri Triomics for Single-Cell Analysis AbCellera Presents Phase 2 Data for ABCL635 Lundbeck Vyepti Receives Japan Approval for Migraine Prevention Skyhawk Therapeutics Reports 15-Month SKY-0515 Results MAIA Biotechnology Doses First U.S. Patient in THIO-101 Kestrel Therapeutics Gains FDA Fast Track for KST-6051 Cogent Biosciences Gains FDA Acceptance for Bezuclastinibm ReEmerge Raises $37M to Advance Brain Injury Technology Vertex Partners With Lindsey Vonn to Highlight JOURNAVX Arrowhead Advances ARO-DIMER-PA in Mixed Hyperlipidemia Jubilant Therapeutics Reports JBI-802 MPN Clinical Data Aptar Pharma and MGH Advance Nose-to-Brain Drug Delivery HDT Bio Leads ARPA-H Program for Personalized RNA Vera Therapeutics TRUTAKNA Shows Two-Year Kidney Benefit Novo Nordisk to Share New Cardiometabolic Data at EASD 2026!